Newsroom | 42040 results

NASHVILLE, Tenn.--(BUSINESS WIRE)--Mosaic Clinical Technologies™ (Mosaic), the technology and AI services division of Radiology Partners (RP), today announced the appointment of Mike Peresie as President of Mosaic. Mike joins Mosaic as a seasoned digital health executive with more than two decades of experience leading high-growth innovation portfolios and scaled software, network and data businesses. He brings deep expertise in building technology platforms that improve access, quality and aff...

TORONTO, Ontario--(BUSINESS WIRE)--Celltrion, Inc. today announced that Health Canada has approved Eydenzelt®, a biosimilar referencing Eylea® (aflibercept 2mg), in both vial and pre-filled syringe format, for treatment of all indications approved for Eylea.1 “Today’s approval lays a solid foundation for Celltrion’s expansion into the Canadian ophthalmology market and represents a significant milestone in diversifying the company’s portfolio,” said Jungyong Shin, Managing Director at Celltrion...

TORONTO, Ontario--(BUSINESS WIRE)--Celltrion, Inc. annoncé aujourd'hui que Santé Canada a approuvé l'Eydenzelt®, un biosimilaire référençant l'Eylea® (aflibercept 2mg), en flacon et en seringue préremplie, pour le traitement de toutes les indications approuvées pour l'Eylea.1 « L’approbation d’aujourd’hui jette des bases solides pour l’expansion de Celltrion sur le marché canadien de l’ophtalmologie et représente une étape importante dans la diversification du portefeuille de la société », décl...

INCHEON, Corea del Sud--(BUSINESS WIRE)--La Commissione Europea (CE) ha approvato l'estensione di linea nell'Unione Europea (UE) per Omlyclo™ (omalizumab) di Celltrion, il primo e unico biosimilare di omalizumab in Europa, per la siringa preriempita (PFS) da 300 mg/2ml. La Commissione Europea (CE) ha approvato la soluzione iniettabile di Omlyclo™ da 75 mg/0,5ml e 150mg/1ml in siringa preriempita nel maggio 2024. Omlyclo™ è indicato nel trattamento di pazienti affetti da asma allergica, orticari...

MANHASSET, N.Y.--(BUSINESS WIRE)--Recent reports show that one in seven first responders have probable post-traumatic stress disorder (PTSD) in response to routine duties with prevalence increasing after responding to a crisis. To improve our understanding and the well-being of these essential heroes, researchers at Northwell Health’s Feinstein Institutes for Medical Research, Stony Brook University and Texas A&M University received a $3.37-million grant from the National Institute of Menta...

DUBLIN--(BUSINESS WIRE)--The "Antibody Contract Development & Manufacturing Organization Market Forecast to 2033" has been added to ResearchAndMarkets.com's offering. The global antibody contract development and manufacturing organization (CDMO) market is poised for substantial growth, with its value estimated at USD 21.1 billion in 2024 and projected to soar to USD 45.8 billion by 2033. This represents a CAGR of 9.38% from 2025 to 2033, driven by a surge in demand for monoclonal antibodies...

DUBLIN--(BUSINESS WIRE)--The "Healthcare Contract Research Organization Market Forecast to 2033" has been added to ResearchAndMarkets.com's offering. The global healthcare contract research organization (CRO) market is projected to expand significantly from USD 55.84 billion in 2024 to USD 105.73 billion by 2033, at a CAGR of 7.42%. This growth is propelled by increased investments in drug development, an upsurge in R&D activities, expanding regulatory requirements, the globalization of cli...

PARIS--(BUSINESS WIRE)--BAT déplore des discussions sur une résolution présentée ce jour devant l’Assemblée nationale, mais qui n’aura aucun effet normatif...

CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) announced today that it has received FDA Premarket Authorization for Pristina Recon DL, an advanced 3D mammography image reconstruction technology. Powered by deep learning, Pristina Recon DL sets a new standard in image definition and sharpness. Breast cancer remains one of the most common cancers among women, with one in eight expected to face a diagnosis in their lifetime2 and an estimated 1.1 million breast cancer–related deaths project...

CIDADE DO MÉXICO--(BUSINESS WIRE)--O Instituto Global de Saúde Pública da AHF para a América Latina e o Caribe, em colaboração com o Laboratório de Políticas de Saúde Pública da Universidade de Miami, convida membros da imprensa para um painel virtual de alto nível intitulado “Por que a América Latina deve agir como um bloco em futuras emergências de saúde? Rumo a uma agenda regional comum de preparação e resposta”. A América Latina está entre as regiões mais afetadas pelas recentes crises de s...